Kars4Kids Faces California Ad Ban Over Charity Affiliation Disclosure Financial Implications SpaceX Delays HighStakes Starship Test Launch IPO Filing Highlights Reliance on Rocket RMBI Q1 2026 Earnings Solid EPS as Bank Navigates Steady Operating Environment Marker Therapeutics Q1 2026 Earnings Loss Narrows as Clinical Progress Continues XORTX Therapeutics Q1 2024 Earnings Steep EPS Miss Highlights PreRevenue Biotech Hurdles RELX Q2 2025 Earnings Slight EPS Beat Amid Modest Stock Decline